For reprint rights or to purchase a copy of your Daily Journal photo, email jeremy@reprintpros.com for prices or call 949-702-5390.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Health Care & Hospital Law

Oct. 12, 2023

GlaxoSmithKline settles 4 bellwether Zantac cases in Alameda County

The London based biopharmaceutical company denied liability in a news release Wednesday. Though it has secured a summary judgment victory against 50,000 claims in Florida federal court, the company still faces more than 4,000 other lawsuits in Alameda County from the plaintiffs attorneys and and 77,000 cases in Delaware.

GlaxoSmithKline LLC agreed on Wednesday to settle four bellwether lawsuits in Alameda County one month before trial was set to begin to determine whether the company’s discontinued heartburn medication, Zantac, causes breast cancer.

The London based biopharmaceutical company denied liability in a news release Wednesday. Though it has secured a summary judgment victory against 50,000 claims in Florida federal court, the company still faces ...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.